baber/WOPTO huggingface dataset:
Patent AU-2021246144-A1 (AU)
Title: Pongamia oil compositions, and methods for producing and using thereof
Inventor: DRAGULL KLAUS
IPC: A01N25/30
Filed: 2021-04-02
Abstract: Provided herein are pongamia oil compositions suitable for animal consumption, in particular human consumption, as well as methods of producing such compositions. The compositions are edible and non-bitter tasting, and have certain attributes that make such compositions suitable for use as and/or in various food and beverage products. Provided herein are also methods of analyzing pongamia oil.
Patent AU-2021254394-A1 (AU)
Title: A shock absorbing device to protect cryopreserved biological material
Inventor: MCCORMICK BRUCE
IPC: A01N1/02
Filed: 2021-04-07
Abstract: A shock absorbing device to protect cryogenically frozen biological material includes an outer sleeve and a foam sleeve. The outer sleeve defines an interior volume and has an opening configured to pass a biological material container into the interior volume. The foam sleeve is in the interior volume and has an opening and an interior cavity. The opening of the foam sleeve is aligned with the opening of the outer sleeve to pass the biological material container into the interior cavity. In another embodiment, the shock absorbing device includes a first layer, a foam layer, and a liner layer to retain the foam layer. A first side of the foam layer is adjacent and facing a second side of the first layer. A first side of the liner layer is adjacent and facing a second side of the foam layer.
Patent AU-2021264922-A1 (AU)
Title: Compositions and methods for emergency rescue
Inventor: HUANG HAIYONG HUGH
IPC: A61N1/04
Filed: 2021-02-26
Abstract: Disclosed in certain embodiments is a parenteral formulation comprising a therapeutically effective amount of an emergency rescue active pharmaceutical ingredient and a parenterally acceptable adjuvant in an amount that enhances the absorption of the emergency rescue active pharmaceutical ingredient (ER-API) into the systemic circulation. The enhanced absorption may be evidence by a faster onset time, a faster T
Patent AU-2021266338-A1 (AU)
Title: Compositions and methods for personalized neoplasia vaccines
Inventor: HACOHEN NIR
IPC: A61K39/00
Filed: 2021-11-12
Abstract: The invention provides a method of making a personalized neoplasia vaccine for a 
subject diagnosed as having a neoplasia, which includes identifying a plurality of mutations in 
5 the neoplasia, analyzing the plurality of mutations to identify a subset of at least five neo
antigenic mutations predicted to encode neo-antigenic peptides, the neo-antigenic mutations 
selected from the group consisting of missense mutations, neoORF mutations, and any 
combination thereof, and producing, based on the identified subset, a personalized neoplasia 
vaccine.  
0
Patent AU-2021269375-A1 (AU)
Title: RFID tag secured to a tire
Inventor: NICULA ADRIAN FLORIAN
IPC: B29D30/00
Filed: 2021-11-17
Abstract: RFID TAG SECURED TO A TIRE 
ABSTRACT 
An RFID tag for attaching to a tire consists of a first polyester layer, a second polyester layer 
adjacent the first polyester layer, the second polyester layer having an etched antenna and an 
RFID chip, and a third polyester layer adjacent the second polyester layer. The third polyester 
layer surrounds part of the first and second layers and is secured by heat to an innerliner of the 
tire.
1/2 
C C\I c) 1- O wO - 00 O) 0 
C)D 
TOM:
Patent AU-2021273607-A1 (AU)
Title: Tire
Inventor: KITAMURA NAOYA
IPC: B60C11/03
Filed: 2021-11-25
Abstract: Provided is a tire comprising a tread formed of a rubber 
composition comprising a rubber component comprising 40 to 80% by 
mass of an isoprene-based rubber, wherein the tire satisfies the 
following conditions (1) to (6): 
(1) when a tan 6 at 30°C (tan 6 30-c) is AA>0.18, 
(2) when a ratio (EB800c/EB23°c) of an elongation at break at 
80°C (EB8o-c) to an elongation at break at 23°C (EB23°c) is B, 0.9B<1.4, 
and 
(3) when an abrasion resistance index with a tire of 
Comparative example 1 being 100 as measured by a LAT tester is C, 
110 C 140, 
(4) when a ratio (LANDSh/LANDcr) of a land ratio of the entire 
pair of shoulder parts (LANDSh) to a land ratio of the crown part (LANDr) 
is D, 0.80D 2.00, 
(5) when a maximum groove depth of the circumferential 
main groove is E (mm), 5 E 20, and 
(6) 25(B x C/A) x (D/E)200.
1/3 
FIG.1 
265/65R 18 
1 SEA: 2920.69 =.C9 
All: 9933.9a 08 8 
LANM1 70.60% 
1_ SA-j _142- 0.66116 ALL: 11846.82 
SEA 2920.69 
ALL: 9933.98 =.758 
LAI7, 7D6C
Patent AU-2021281382-A1 (AU)
Title: Sampling device for storing at least one sample of animal tissue, corresponding method for collecting and system for identifying an animal
Inventor: TEYCHENE BRUNO
IPC: A61B10/02
Filed: 2021-05-25
Abstract: The disclosure concerns a sampling device (50), adapted to cooperate with a sampling member (9) subsequent to collection of a sample of animal tissue, said sampling device (50) comprising: - a receiving tube (51) designed for receiving said sample of animal tissue, containing at least one specific agent (54) and comprising an inlet (510); - a tube head (52) removably attached to said inlet (510) of said receiving tube and provided with a through channel ending in the receiving tube (520); - a closing element (53) being configured to take at least two positions: • one first position, in which said closing element (53) is held into said tube head (52) so as to plug said through channel (520) of said tube head (52), and • one second position, in which said closing element (53) is released into said receiving tube (51).
Patent AU-2021303717-A1 (AU)
Title: Specific binding molecules
Inventor: LEONARD SARAH
IPC: C07K14/725
Filed: 2021-07-05
Abstract: The present invention relates to specific binding molecules which bind to the HLA-E restricted peptide RLPAKAPLL (SEQ ID NO: 1) derived from Mycobacterium tuberculosis enoyl-ACP reductase. Said specific binding molecules may comprise CDR sequences embedded within a framework sequence. The CDRs and framework sequences may correspond to a T cell receptor (TCR) variable domain and may further comprise non-natural mutations relative to a native TCR variable domain. The specific binding molecules of the invention are particularly suitable for use as novel immunotherapeutic reagents for the treatment of infectious disease.
Patent AU-2021304246-A1 (AU)
Title: Method for producing a crosslinked lignin with a highly specified surface area, crosslinked lignin, and technical rubber articles or tires comprising crosslinked lignin
Inventor: DAUTZENBERG GEERTJE
IPC: C07G1/00
Filed: 2021-07-09
Abstract: The invention relates to a method for producing a crosslinked lignin in particle form using a hydrothermal treatment of a liquid, which is made of black liquor, contains lignin and a crosslinker or a precursor thereof, and has an electrical activity ranging from more than 15 mS/cm, preferably more than 25 mS/cm, to 400 mS/cm, and to the crosslinked lignin produced using the aforementioned method. The invention additionally relates to crosslinked lignin particles which have a glass transition temperature Tg of at least 160 °C or no glass transition temperature and an STSA surface area of at least 10 m
Patent AU-2021325371-A1 (AU)
Title: Process for the preparation of quaternized pyridazine derivatives
Inventor: SMEJKAL TOMAS
IPC: C07D401/04
Filed: 2021-08-13
Abstract: The present invention provides, inter alia, a process for producing a compound of formula (I) wherein the substituents are as defined in claim 1. The present invention further provides intermediate compounds utilised in said process, and methods for producing said intermediate compounds.
Patent AU-2021331773-A1 (AU)
Title: Parameter configuration apparatus
Inventor: WANG JING
IPC: H04B3/54
Filed: 2021-07-12
Abstract: Provided is a parameter configuration apparatus, comprising a first signal modulation element, a second signal modulation element and an operation element, wherein the operation element is electrically connected to the first signal modulation element or the second signal modulation element; the operation element is used for outputting a configuration signal current; the first signal modulation element and the second signal modulation element have a combined state and a detached state; when the first signal modulation element and the second signal modulation element are in the combined state, the first signal modulation element is electrically connected to the second signal modulation element, and the first signal modulation element and the second signal modulation element define a configuration space for a cable to pass therethrough; and when the first signal modulation element and the second signal modulation element are in the detached state, the first signal modulation element is detached from the second signal modulation element. By means of the embodiments of the present disclosure, a parameter configuration operation is made easier and is low cost.
Patent AU-2021370358-A1 (AU)
Title: Native whey protein composition for improving gastro-intestinal tolerance
Inventor: RENES INGRID BRUNHILDE
IPC: A23C9/142
Filed: 2021-10-26
Abstract: The invention concerns a native whey protein composition with profound amounts of native whey protein and with beta-casein for use in the treatment and/or prevention of gastrointestinal intolerance. The inventors found that the native whey protein composition relatively high in beta- casein and low in kappa- and alpha-casein provides a beneficial effect on gastrointestinal intolerance.
Patent AU-2021382668-A1 (AU)
Title: Cyclobenzaprine treatment for alcohol use disorder
Inventor: LEDERMAN SETH
IPC: A61K31/438
Filed: 2021-11-19
Abstract: The present disclosure provides a method for treating alcohol use disorder (AUD) and associated symptoms to a subject in need thereof by administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of cyclobenzaprine or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. The pharmaceutically acceptable salt comprises a cyclobenzaprine acid salt.
Patent AU-2021391949-A1 (AU)
Title: Oral formulations of tenapanor
Inventor: GUNNARSSON CECILIA
IPC: A61K9/16
Filed: 2021-12-06
Abstract: The present invention provides a pharmaceutical tablet formulation of tenapanor that is chemically stable and soluble comprising greater than about 6% w/w of amorphous tenapanor in its bis-HCl form, an acidifying agent, an antioxidant, a disintegrant, a lubricant, a glidant, a filler, and an immediate release coating, wherein the total chloride content of the active ingredient is greater than 5.82% and the particle diameter distribution D50 is from about from about 18μm to about 22μm.
Patent AU-2021447431-A1 (AU)
Title: A downhole assembly with spring isolation filter
Inventor: GARCIA MARIANO
IPC: E21B47/01
Filed: 2021-05-27
Abstract: The present invention is directed to an apparatus for use on a structural member having a longitudinal axis, the structural member being configured to propagate stress wave energy in an operational state, the stress wave energy being characterized by an operational frequency spectrum. The apparatus has a housing assembly including a first end, a second end, and one or more protective enclosures configured to accommodate one or more devices. The housing assembly is configured to be rotationally registered to the structural member when coupled to the structural member, and is characterized by a predetermined housing mass. A spring arrangement is coupled between the structural member and the first end and/or coupled between the structural member and the second end in the operational state. The spring arrangement is characterized by a predetermined force-displacement relationship. The housing assembly and the spring arrangement form an isolation filter characterized by a predetermined spectral transfer function, the predetermined spectral transfer function being a function of the predetermined housing mass and the predetermined force-displacement relationship. The predetermined spectral transfer function includes a passband having frequencies that are substantially outside the operational frequency spectrum wherein the stress wave energy is substantially attenuated in the operational state so that the housing member is substantially isolated from the stress wave energy.
Patent AU-2022200241-A1 (AU)
Title: Air hockey tabletop assembly and table comprising same
Inventor: HAO GUAN
IPC: A63B67/04
Filed: 2022-01-14
Abstract: An air hockey tabletop assembly comprising at least two segments, each defining a 
respective portion of an air hockey playing surface, the assembly being configurable 
5 between: 
(a) an assembled state wherein the segments are joined and supported by 
a table so as to define the playing surface; and 
(b) a disassembled state wherein each segment is removable from the 
table.  
10
4/7 
4 
14a 12a 12b 14b 
26 
24 26 28 2 20 
FIGURE 4
Patent AU-2022200413-A1 (AU)
Title: Printer head for 3D printer and methods of using same
Inventor: ELLIS DAVID MAXWELL
IPC: B29K67/00
Filed: 2022-01-21
Abstract: A printer head for a 3D printer is disclosed. The printer head comprises a heat block 
comprising a body, the body defining a filament inlet, a filament outlet, and a filament 
pathway connecting the filament inlet and the filament outlet. The heat block is 
configured to melt a filament of a printing material in the filament pathway. The 
filament pathway comprises at least one arcuate portion.
3/7 
z 
160 y 
Y 
210 
37513 
1336 
370 395 
352
340, 350 
312, 314 
300, 310 
230 
300, 390 
- 392, 394 
322, 324 340, 360 
362 
380 
375 
300, 330 
332, 334 
300, 320 
220 
136 
Fig.3A
Patent AU-2022202625-A1 (AU)
Title: Methods and compositions for rapid nucleic acid library preparation
Inventor: BROWN KEITH
IPC: C12Q1/68
Filed: 2022-04-20
Abstract: METHODS AND COMPOSITIONS FOR RAPID NUCLEIC ACID LIBRARY 
PREPARATION 
ABSTRACT OF THE DISCLOSURE 
Rapid nucleic acid libraries, methods of generation, kits, and compositions relating 
to library synthesis, including reagents, intermediaries and final products are disclosed herein.  
The disclosure enables rapid synthesis of libraries that allow independent verification of 
sequence information and rapid identification of sequence information with template of 
origin.
Patent AU-2022202960-A1 (AU)
Title: Systems and methods for shunting fluid
Inventor: ANAND P J
IPC: A61M25/14
Filed: 2022-05-03
Abstract: A method of shunting body fluid, comprising: inserting a catheter having first and second flexible tips 
extending from a distal end thereof and coupled to one another into a fluid-containing cavity such 
that fluid can flow out of the cavity through the catheter; and decoupling the first and second tips 
such that pulsatile flow of fluid within the cavity causes the first and second tips to strike one 
another, thereby dislodging obstructions from the first and second tips.
Patent AU-2022203382-A1 (AU)
Title: Automobile chassis
Inventor: LIU XINNA
IPC: B62D29/00
Filed: 2022-05-19
Abstract: Disclosed is an automobile chassis, which includes a chassis main beam, a chassis 
cross beam and a support cross beam. The quantity of the chassis main beams is two.  
The two chassis main beams are arranged in parallel. A section shape of the chassis 
main beam is "LJ", and the openings of the two chassis main beams are arranged 
opposite. The quantity of the support cross beams is more than one. All the support 
cross beams are arranged between the two chassis main beams. A length direction of the 
support cross beam is perpendicular to a length direction of the chassis main beam. The 
chassis cross beam is arranged at an end of the chassis main beam, and both ends of the 
chassis cross beam are respectively connected and fixed with the two chassis main 
beams.
1/4 
FIG1 
1
Patent AU-2022205421-A1 (AU)
Title: Factor b proteases
Inventor: POPKOV MIKHAIL
IPC: A61K38/48
Filed: 2022-01-10
Abstract: Provided herein are engineered proteases of the S1A family that are specific for, and capable of, cleaving Factor B. Also provided herein are methods of making and using such engineered proteases. The engineered proteases provided herein may be useful for treating a disease or condition associated with dysregulation of the complement system by reducing complement activation through cleavage and inactivation of Factor B.
Patent AU-2022212481-A1 (AU)
Title: A nest for the packaging of plunger stoppers with clips ensuring a reliable alignment of several nests in a tub
Inventor: EYMERY ANAÏS
IPC: B01L9/00
Filed: 2022-01-26
Abstract: A nest and tub arrangement (10) for the storage of medical device components including a tub (12) and at least one nest (14). The tub (12) includes four side surfaces (16, 17) and a plurality of guide ribs (22) extending vertically along the side surfaces (16, 17), wherein the plurality of guide ribs (22) are inwardly directed and include a friction surface (25) extending vertically thereon. The at least one nest (14) includes a top surface (35), a bottom surface (36), a plurality of receptacles (24) for the storage of a plurality of medical device components therein, and a plurality of deflectable clips (30) positioned on side surfaces (28, 29) of the at least one nest (14). A position of each of the plurality of deflectable clips (30) of the at least one nest (14) corresponds to a position of a respective one of the plurality of guide ribs (22) of the tub (12), and a portion of each of the plurality of deflectable clips (30) is configured to contact a corresponding friction surface (25) of a respective one of the plurality of guide ribs (22) so as to laterally deflect each of the plurality of deflectable clips (30) inward to align and secure the at least one nest (14) within the tub (12).
Patent AU-2022215306-A1 (AU)
Title: Lithium extraction method
Inventor: HAYNES BRIAN
IPC: C01D15/08
Filed: 2022-08-12
Abstract: According to the present invention there is provided a method for the 
extraction of lithium from one or more lithium-containing ores such as 
spodumene, the inventive method comprising the steps of: milling said ore/s to a 
predetermined average particle size; optionally calcining the milled ore; further 
optionally performing a secondary milling step; providing an aqueous suspension 
of the one or more lithium-containing ores at a predetermined solids 
concentration; subjecting the one or more lithium-containing ores to an aqueous 
extraction medium defined by a predetermined partial pressure of C02, a 
predetermined extraction temperature, over a predetermined time; and obtaining 
technical grade lithium carbonate/lithium bicarbonate therefrom. Optional 
concentration and/or precipitation/purification steps may follow.
Patent AU-2022246797-A1 (AU)
Title: Systems and methods for additive manufacturing of metal nitride ceramics
Inventor: BADWE SUNIL
IPC: B22F3/105
Filed: 2022-03-28
Abstract: Described herein are embodiments directed to additive manufacturing (AM), including three-dimensional (3D) printing, of metal nitride ceramics. In some embodiments herein, AM may comprise powder bed fusion (PBF) techniques. Also described herein are metal nitride ceramic components formed by AM techniques.
Patent AU-2022271833-A1 (AU)
Title: Methods of treating liver diseases with phosphodiesterase 3b (pde3b) inhibitors
Inventor: VERWEIJ NIEK
IPC: A61P1/16
Filed: 2022-05-10
Abstract: The present disclosure provides methods of treating a subject having a liver disease or type 2 diabetes, and methods of identifying subjects having an increased risk of developing a liver disease or type 2 diabetes.
Patent AU-2022291548-A1 (AU)
Title: Intraocular lenses having zone-by-zone step height control
Inventor: LEE SHINWOOK
IPC: G02B27/42
Filed: 2022-12-22
Abstract: A method and system provide an ophthalmic device. The ophthalmic 
device includes an ophthalmic lens having anterior surface, a posterior surface 
and at least one diffractive structure including a plurality of zones. The at least 
one diffractive structure is for at least one of the anterior surface and the 
posterior surface. Each zone includes at least one echelette having a least one 
step height. The step height(s) are individually optimized for each zone. To 
compensate chromatic aberration of eye from distance to a range of vision, a 
greater than 2x phase step height may be employed and the step height(s) 
folded by a phase, which is an integer multiple of two multiplied by m. Hence 
chromatic aberration of eye may be compensated to improve vision from 
distance to near.
Patent AU-2022334813-A1 (AU)
Title: Use of a colloidal polymer inorganic hybrid material as a construction composition additive
Inventor: SACHSENHAUSER BERNHARD
IPC: C04B28/04
Filed: 2022-08-26
Abstract: A colloidal polymer inorganic hybrid material is used as an additive for a construction composition comprising a binder system, the binder system comprising a cementitious binder and at least one supplementary cementitious material, wherein the supplementary cementitious material(s) comprise(s) a calcined clay material, the clay material including at least one non-kaolinitic clay material. The hybrid material comprises at least one polyvalent metal cation, at least one polymeric dispersant which comprises anionic and/or anionogenic groups and polyether side chains, at least one anion which is able to form a low-solubility salt with the polyvalent metal cation, wherein the polyvalent metal cation is present in an amount corresponding to the following formula (1), and the anion is present in an amount corresponding to the following formula (2), wherein φ is the charge density of the polymeric, mD is the amount of polymeric dispersant, Z
Patent AU-2022334998-A1 (AU)
Title: Implantable stimulator with an electrode array, conformable substrate, and mechanical strain relief
Inventor: MARTENS HUBERT CECILE FRANCOIS
IPC: A61N1/05
Filed: 2022-08-24
Abstract: An implantable stimulator has a substrate 300, 1400 comprising a first portion 2010, 2110, 2210, 2310 with a pulse generator 500, and a conformable portion 2020, 2120, 2320 with an electrode array 200, 400, 1220. Electrical interconnections 250, 1210 are provided to the pulse generator with an electrical interface comprising an electrically conductive elastomer 2260. An encapsulation layer 1300, 1310, 1320, 2150, 2250 is provided, configured to resist separation of the conformable portion from the first portion at the meeting of the first and conformable portions. The conformable portion has a thickness equal to or less than 0.5 millimeters. Optionally, a mechanical brace 2140, 2240, 2340 is provided at the meeting of the first and conformable portions to further resist separation. By providing an encapsulant, a conductive elastomer may be used to simplify manufacturing or repair. An ACA elastomer such as ACF provides a high separation resistance to longitudinal forces.
Patent AU-2023201301-A1 (AU)
Title: Test device for analyte in a fluid sample
Inventor: FANG JIANQIU
IPC: G01N33/52
Filed: 2023-03-02
Abstract: The present invention provides a test device. The device includes a testing element and a 
housing accommodating the testing element; the housing is formed by folding a card which is made of a 
paper material. The testing element is located in the housing, and the housing is allowed to be in 
different change states to achieve the detection or assay of an analyte in a sample.